Gertraud Orend

6PUBLICATIONS
34CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markersCancer diagnosisStructure and dynamics of materials
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Mar 31, 2026
Tenascin-C orchestrates radiotherapy-induced head and neck tumor regression.

Thomas Loustau, Ioanna Mitrentsi, Nuohan Wang

|Oct 09, 2024
Targeting the MAtrix REgulating MOtif abolishes several hallmarks of cancer, triggering antitumor immunity.

Chengbei Li, Amanpreet Kaur, Alexia Pavlidaki

|May 13, 2023
Investigating Chemokine-Matrix Networks in Breast Cancer: Tenascin-C Sets the Tone for CCL2.

Martha Gschwandtner, Anís N Gammage, Claire Deligne

|Sep 14, 2022
Advances on the roles of tenascin-C in cancer.

Alev Yilmaz, Thomas Loustau, Nathalie Salomé

|May 14, 2021
Tenascin-C immobilizes infiltrating T lymphocytes through CXCL12 promoting breast cancer progression.

Devadarssen Murdamoothoo, Zhen Sun, Alev Yilmaz

|Nov 23, 2016
Tenascin-C at a glance.

Kim S Midwood, Matthias Chiquet, Richard P Tucker

Pageof 1

Frequent Collaborators

5 joint publications

Thomas Loustau

4 joint publications

Raphael Carapito

3 joint publications

Manuel Koch

2 joint publications

Nathalie Salomé